+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Efficacy of recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenia



Efficacy of recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenia



Aids 7(4): 589-590




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 042972015

Download citation: RISBibTeXText

PMID: 7685174

DOI: 10.1097/00002030-199304000-00021


Related references

Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias. Recenti Progressi in Medicina 84(7-8): 526-530, 1993

Efficacy of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with AIDS. Aids 4(12): 1251-1255, 1990

Long-term treatment with recombinant human granulocyte colony stimulating factor in patients with severe congenital neutropenia. Klinische Padiatrie 205(4): 264-271, 1993

Cyclic neutropenia: natural history and effects of long-term treatment with recombinant human granulocyte colony-stimulating factor. Cancer Investigation 11(2): 219-223, 1993

Safety and efficacy study of the recombinant granulocyte colony-stimulating factor for prevention of neutropenia and neutropenia-related complications in women with metastatic breast cancer receiving docetaxel/doxorubicin. Medicina 45(8): 600-606, 2009

Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex. Blood 78(12): 3148-3154, 1991

Recombinant granulocyte colony stimulating factor and recombinant erythropoietin may abrogate the neutropenia and anemia of aids and may allow for resumption of zidovudine azt in patients with aids. Morisset, R A (Ed ) Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 550, 1989

The effect of recombinant human granulocyte macrophage colony stimulating factor on neutropenia and related morbidity in chronic severe neutropenia. Annals of Internal Medicine 111(11): 887-892, 1989

Double-blind, randomized comparison of the safety profile of granulocyte macrophage colony stimulating factor vs recombinant granulocyte colony stimulating factor in advanced HIV infected patients with neutropenia. Program and Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 33: 246, 1993

Decreased levels of myeloid progenitor cells associated with long-term administration of recombinant human granulocyte colony-stimulating factor in patients with autoimmune neutropenia. British Journal of Haematology 83(3): 384-387, 1993

Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factor. JAMA 270(9): 1132-1133, 1993

Recombinant granulocyte colony-stimulating factor (rG-CSF) in HIV patients with zidovudine related neutropenia. Journal of Nutritional Science and Vitaminology Spec No: 353-356, 1992

Recombinant granulocyte colony stimulating factor rg csf in hiv patients p with zidovudine z related neutropenia. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 44b, 1991

Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia. International Journal of Hematology 71(2): 136-143, 2000

Granulocyte colony stimulating factor in HCV genotype-1 patients who develop Peg-IFN-alpha2b related severe neutropenia: a preliminary report on treatment, safety and efficacy. Journal of Medical Virology 81(5): 848-852, 2009